Jump to content

Jean-Luc Bélingard

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by McSyl (talk | contribs) at 16:50, 18 June 2024 (Jean-Luc Bélingard). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Jean-Luc Bélingard
Born (1948-10-28) 28 October 1948 (age 75)
Nantes, France
Alma materHEC Paris
Cornell University
OccupationFormer CEO of bioMérieux

Jean-Luc Bélingard, born in 1948, is a French business executive, chairman and CEO of bioMérieux from 2011 to December 2017.

Biography

Jean-Luc Bélingard is a graduate of HEC Paris and holds an MBA from Cornell University.[1]

He had a career in the pharmaceutical industry, notably at Merck & Co. and Hoffmann-La Roche where he was a member of the group's executive committee and general manager of Roche Diagnostic. From 2002 to 2010, he served as Chairman and CEO of the Ipsen group, a French pharmaceutical group present in several therapeutic areas including oncology, neurology and endocrinology.[2]

As of January 1, 2011, he joined BioMérieux as Chairman and CEO. Alexandre Mérieux succeeded him in December 2017.

He is also a director of Celera Genomics and Laboratory Corporation of America.[3]

References

  1. ^ Le président de bioMérieux Jean-Luc Bélingard élu à la tête de la Fédération des industries de Santé
  2. ^ BioMérieux : Alain Mérieux cède son fauteuil de PDG à Jean-Luc Bélingard
  3. ^ bioMérieux: Jean-Luc Bélingard PDG
Retrieved from "https://en.wikipedia.org/w/index.php?title=Jean-Luc_Bélingard&oldid=1229770567"